Trial intelligence / Profile preview

Metformin vs CLA in Obese Pediatric Patients

NCT02063802Phase 2Unknown

Sponsor
Laboratorios Silanes
Start
Aug 2012
Primary completion
May 2014
Countries
1
01

Overview

Phase 2, randomised trial (3 arms), sponsored by Laboratorios Silanes. Primary endpoints: Change from baseline in body mass index at 4 months, Change in body fat mass at 4 months and 1 more. Status: unknown.

Beyond the preview

Go deeper on NCT02063802.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02063802.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call